Matti Sillanpää, PhD, MD; Mika Gissler, DrPhil; Dieter Schmidt, MD
free access
has audio
JAMA Neurol. 2016;73(4):390-395. doi:10.1001/jamaneurol.2015.4515
This study using a long-term national register aims to determine whether progress has been made in the prevention of epilepsy in Finland during the last 40 years.
-
Podcast:
Efforts in Epilepsy Prevention in the Last 40 Years (JAMA Neurology)
-
Editorial
The Prevention of Epilepsy
Mark Agostini, MD
JAMA Neurol
E. Murat Arsava, MD; Gyeong-Moon Kim, MD, PhD; Jamary Oliveira-Filho, MD, MS, PhD; et al.
free access
JAMA Neurol. 2016;73(4):396-401. doi:10.1001/jamaneurol.2015.4949
This study tests the validity of a prognostic score that was exclusively developed to predict early risk of recurrence in a multicenter setting.
-
Editorial
Predicting Early Recurrent Stroke With the Recurrence Risk Estimator
Graeme J. Hankey, MD, FRACP, FRCP, FAHA; Chee-Keong Wee, MBBS, MRCP
JAMA Neurol
Helena M. van der Holst, MD; Ingeborg W. M. van Uden, MD; Anil M. Tuladhar, MD; et al.
free access
JAMA Neurol. 2016;73(4):402-409. doi:10.1001/jamaneurol.2015.4560
This observational study examines factors affecting 8-year mortality in elderly patients with cerebral small vessel disease.
Willy Gomm, PhD; Klaus von Holt, MD, PhD; Friederike Thomé, MSc; et al.
free access
JAMA Neurol. 2016;73(4):410-416. doi:10.1001/jamaneurol.2015.4791
This cohort study examines the association between the use of proton pump inhibitors and the risk of incident dementia in an elderly German population.
Thaís Armangué, MD, PhD; Lidia Sabater, PhD; Estefanía Torres-Vega, BSc; et al.
free access
JAMA Neurol. 2016;73(4):417-424. doi:10.1001/jamaneurol.2015.4607
This cohort study examines the clinical and immunological features of 114 patients with opsoclonus-myoclonus syndrome, including their neuronal cell surface antibodies.
Adriano Chiò, MD; Maura Brunetti, BSc; Marco Barberis, BSc; et al.
free access
JAMA Neurol. 2016;73(4):425-430. doi:10.1001/jamaneurol.2015.4773
This study assesses the influence of the APOE and C9ORF72 genotypes on cognitive impairment in a population-based series of Italian patients with amyotrophic lateral sclerosis.
-
Editorial
To Dement or Not to Dement, That Is the Question
Bryan J. Traynor, MD, PhD; Yevgeniya A. Abramzon, BS
JAMA Neurol
Daniel C. Aguirre-Acevedo, PhD; Francisco Lopera, MD; Eliana Henao, MS; et al.
free access
JAMA Neurol. 2016;73(4):431-438. doi:10.1001/jamaneurol.2015.4851
This study evaluates the onset and rate of cognitive decline during preclinical autosomal dominant Alzheimer disease and the effect of socioeconomic, vascular, and genetic factors on the cognitive decline.
-
Editorial
Cognitive Decline in Presymptomatic Alzheimer Disease
Diane B. Howieson, PhD, ABPP-CN
JAMA Neurol
Rabe E. Alhurani, MBBS; Maria Vassilaki, MD, PhD; Jeremiah A. Aakre, MPH; et al.
free access
JAMA Neurol. 2016;73(4):439-446. doi:10.1001/jamaneurol.2015.4756
This cohort study investigates the association between midlife change in weight and body mass index and onset of mild cognitive impairment.
Simon Mead, PhD; Matthew Burnell, PhD; Jessica Lowe, BSc; et al.
free access
JAMA Neurol. 2016;73(4):447-455. doi:10.1001/jamaneurol.2015.4885
This interval-cohort study aims to establish a more powerful and meaningful clinical trial method in sporadic Creutzfeldt-Jakob disease.
Tze Pin Ng, MD; Liang Feng, PhD; Ma Shwe Zin Nyunt, PhD; et al.
free access
JAMA Neurol. 2016;73(4):456-463. doi:10.1001/jamaneurol.2015.4899
This longitudinal study investigates the association of the metabolic syndrome and its component cardiovascular risk factors with the incidence of mild cognitive impairment and its progression to dementia.